Malignant peritoneal mesothelioma
MONDO:0005512An aggressive malignant mesothelioma that arises from the peritoneum. Patients usually present with abdominal pain and ascites.
Also known as: advanced malignant mesothelioma of peritoneum, advanced malignant mesothelioma of the peritoneum, advanced peritoneal malignant mesothelioma, diffuse malignant peritoneal mesothelioma, malignant mesothelioma (disease) of peritoneum, malignant peritoneal mesothelioma, advanced, peritoneal mesothelioma (disease), malignant, peritoneum malignant mesothelioma (disease)
2750 clinical trials for this condition and its sub-types, 13 tagged with Malignant peritoneal mesothelioma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Immune booster shows promise against rare cancer
Disease control CompletedThis study tested a drug called pembrolizumab in 65 people with malignant mesothelioma, a rare cancer of the lining around the lungs or abdomen. The drug works by helping the immune system attack cancer cells. The goal was to see if it could shrink tumors or slow the disease, but…
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New hope for mesothelioma patients who Can't have surgery?
Disease control CompletedThis study tested a chemotherapy drug called paclitaxel, given directly into the abdomen, for people with a rare cancer called malignant peritoneal mesothelioma. The 7 participants could not have standard surgery. The main goal was to find the safest dose and see if the treatment…
Phase 1/2 • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Jun 26, 2026 13:22 UTC
-
Glow-in-the-Dark dye helps surgeons find hidden cancer spots
Diagnosis CompletedThis study tested a new imaging system that uses a fluorescent dye to help surgeons see cancer that has spread to the lining of the abdomen (peritoneum) during surgery. 18 adults with stomach, ovarian, or mesothelioma cancers that had spread to the abdomen were injected with the …
Phase 1/2 • Sponsor: Lumicell, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC